No headlines found.
Avinger Reports Third Quarter 2024 Results
ACCESSWIRE (Thu, 7-Nov 4:06 PM ET)
Avinger to Announce Third Quarter 2024 Results on November 7, 2024
ACCESSWIRE (Tue, 29-Oct 8:01 AM ET)
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Avinger trades on the NASDAQ stock market under the symbol AVGR.
As of January 27, 2025, AVGR stock price declined to $0.57 with 125,697 million shares trading.
AVGR has a beta of 2.45, meaning it tends to be more sensitive to market movements. AVGR has a correlation of 0.07 to the broad based SPY ETF.
AVGR has a market cap of $1.83 million. This is considered a Sub-Micro Cap stock.
Last quarter Avinger reported $2 million in Revenue and -$1.82 earnings per share. This beat revenue expectation by $20,000 and exceeded earnings estimates by $.21.
In the last 3 years, AVGR traded as high as $104.91 and as low as $.39.
The top ETF exchange traded funds that AVGR belongs to (by Net Assets): VXF.
AVGR has underperformed the market in the last year with a price return of -80.1% while the SPY ETF gained +24.4%. AVGR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -31.1% and -28.8%, respectively, while the SPY returned +3.9% and +3.1%, respectively.
AVGR support price is $.52 and resistance is $.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVGR shares will trade within this expected range on the day.